311 related articles for article (PubMed ID: 1868826)
1. The refined 2.15 A X-ray crystal structure of human liver cathepsin B: the structural basis for its specificity.
Musil D; Zucic D; Turk D; Engh RA; Mayr I; Huber R; Popovic T; Turk V; Towatari T; Katunuma N
EMBO J; 1991 Sep; 10(9):2321-30. PubMed ID: 1868826
[TBL] [Abstract][Full Text] [Related]
2. Probing the specificity of cysteine proteinases at subsites remote from the active site: analysis of P4, P3, P2' and P3' variations in extended substrates.
Portaro FC; Santos AB; Cezari MH; Juliano MA; Juliano L; Carmona E
Biochem J; 2000 Apr; 347 Pt 1(Pt 1):123-9. PubMed ID: 10727410
[TBL] [Abstract][Full Text] [Related]
3. Quantitative evaluation of each catalytic subsite of cathepsin B for inhibitory activity based on inhibitory activity-binding mode relationship of epoxysuccinyl inhibitors by X-ray crystal structure analyses of complexes.
Watanabe D; Yamamoto A; Tomoo K; Matsumoto K; Murata M; Kitamura K; Ishida T
J Mol Biol; 2006 Oct; 362(5):979-93. PubMed ID: 16950396
[TBL] [Abstract][Full Text] [Related]
4. Crystal structure of porcine cathepsin H determined at 2.1 A resolution: location of the mini-chain C-terminal carboxyl group defines cathepsin H aminopeptidase function.
Guncar G; Podobnik M; Pungercar J; Strukelj B; Turk V; Turk D
Structure; 1998 Jan; 6(1):51-61. PubMed ID: 9493267
[TBL] [Abstract][Full Text] [Related]
5. Characterization by spectroscopic, kinetic and equilibrium methods of the interaction between recombinant human cystatin A (stefin A) and cysteine proteinases.
Pol E; Olsson SL; Estrada S; Prasthofer TW; Björk I
Biochem J; 1995 Oct; 311 ( Pt 1)(Pt 1):275-82. PubMed ID: 7575465
[TBL] [Abstract][Full Text] [Related]
6. Substrate specificity of bovine cathepsin B and its inhibition by CA074, based on crystal structure refinement of the complex.
Yamamoto A; Tomoo K; Hara T; Murata M; Kitamura K; Ishida T
J Biochem; 2000 Apr; 127(4):635-43. PubMed ID: 10739956
[TBL] [Abstract][Full Text] [Related]
7. Engineering the S2 subsite specificity of human cathepsin S to a cathepsin L- and cathepsin B-like specificity.
Brömme D; Bonneau PR; Lachance P; Storer AC
J Biol Chem; 1994 Dec; 269(48):30238-42. PubMed ID: 7982933
[TBL] [Abstract][Full Text] [Related]
8. Fluorogenic peptide substrates for carboxydipeptidase activity of cathepsin B.
Stachowiak K; Tokmina M; Karpińska A; Sosnowska R; Wiczk W
Acta Biochim Pol; 2004; 51(1):81-92. PubMed ID: 15094828
[TBL] [Abstract][Full Text] [Related]
9. Grafting of features of cystatins C or B into the N-terminal region or second binding loop of cystatin A (stefin A) substantially enhances inhibition of cysteine proteinases.
Pavlova A; Björk I
Biochemistry; 2003 Sep; 42(38):11326-33. PubMed ID: 14503883
[TBL] [Abstract][Full Text] [Related]
10. Crystal structure of the wild-type human procathepsin B at 2.5 A resolution reveals the native active site of a papain-like cysteine protease zymogen.
Podobnik M; Kuhelj R; Turk V; Turk D
J Mol Biol; 1997 Sep; 271(5):774-88. PubMed ID: 9299326
[TBL] [Abstract][Full Text] [Related]
11. Crystal structures of recombinant rat cathepsin B and a cathepsin B-inhibitor complex. Implications for structure-based inhibitor design.
Jia Z; Hasnain S; Hirama T; Lee X; Mort JS; To R; Huber CP
J Biol Chem; 1995 Mar; 270(10):5527-33. PubMed ID: 7890671
[TBL] [Abstract][Full Text] [Related]
12. Crystal and molecular structure of the sulfhydryl protease calotropin DI at 3.2 A resolution.
Heinemann U; Pal GP; Hilgenfeld R; Saenger W
J Mol Biol; 1982 Nov; 161(4):591-606. PubMed ID: 6759664
[TBL] [Abstract][Full Text] [Related]
13. Structural and functional aspects of papain-like cysteine proteinases and their protein inhibitors.
Turk B; Turk V; Turk D
Biol Chem; 1997; 378(3-4):141-50. PubMed ID: 9165064
[TBL] [Abstract][Full Text] [Related]
14. Hybrids of chicken cystatin with human kininogen domain 2 sequences exhibit novel inhibition of calpain, improved inhibition of actinidin and impaired inhibition of papain, cathepsin L and cathepsin B.
Auerswald EA; Nägler DK; Gross S; Assfalg-Machleidt I; Stubbs MT; Eckerskorn C; Machleidt W; Fritz H
Eur J Biochem; 1996 Feb; 235(3):534-42. PubMed ID: 8654398
[TBL] [Abstract][Full Text] [Related]
15. S2' substrate specificity and the role of His110 and His111 in the exopeptidase activity of human cathepsin B.
Krupa JC; Hasnain S; Nägler DK; Ménard R; Mort JS
Biochem J; 2002 Feb; 361(Pt 3):613-9. PubMed ID: 11802791
[TBL] [Abstract][Full Text] [Related]
16. Cathepsins X and B can be differentiated through their respective mono- and dipeptidyl carboxypeptidase activities.
Therrien C; Lachance P; Sulea T; Purisima EO; Qi H; Ziomek E; Alvarez-Hernandez A; Roush WR; Ménard R
Biochemistry; 2001 Mar; 40(9):2702-11. PubMed ID: 11258881
[TBL] [Abstract][Full Text] [Related]
17. Crystal structure of Stefin A in complex with cathepsin H: N-terminal residues of inhibitors can adapt to the active sites of endo- and exopeptidases.
Jenko S; Dolenc I; Guncar G; Dobersek A; Podobnik M; Turk D
J Mol Biol; 2003 Feb; 326(3):875-85. PubMed ID: 12581647
[TBL] [Abstract][Full Text] [Related]
18. The role of Gly-4 of human cystatin A (stefin A) in the binding of target proteinases. Characterization by kinetic and equilibrium methods of the interactions of cystatin A Gly-4 mutants with papain, cathepsin B, and cathepsin L.
Estrada S; Nycander M; Hill NJ; Craven CJ; Waltho JP; Björk I
Biochemistry; 1998 May; 37(20):7551-60. PubMed ID: 9585570
[TBL] [Abstract][Full Text] [Related]
19. The contribution of N-terminal region residues of cystatin A (stefin A) to the affinity and kinetics of inhibition of papain, cathepsin B, and cathepsin L.
Estrada S; Pavlova A; Björk I
Biochemistry; 1999 Jun; 38(22):7339-45. PubMed ID: 10353845
[TBL] [Abstract][Full Text] [Related]
20. The binding mode of an E-64 analog to the active site of cathepsin B.
Feng MH; Chan SL; Xiang Y; Huber CP; Lim C
Protein Eng; 1996 Nov; 9(11):977-86. PubMed ID: 8961350
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
